By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verenium Corporation 

4955 Directors Place

San Diego  California  92121  U.S.A.
Phone: 800-526-5000 Fax: n/a


Verenium Corporation (Nasdaq: VRNM) was formed in June of 2007 through the merger of Diversa Corporation, a global leader in industrial enzyme discovery and development, and Celunol Corporation, a company on the forefront of developing cellulosic ethanol.

Verenium is using its proprietary technologies and world-class expertise in pre-treatment, novel enzyme development, fermentation, engineering and project development to accelerate the development and commercialization of cellulosic ethanol from a wide array of feedstocks, including sugarcane bagasse, dedicated energy crops, agricultural waste and wood products.

By using theses integrated end-to-end capabilities, Verenium is positioned to be the first to produce cellulosic ethanol on a commercial-scale.

In addition, the Company discovers and optimizes enzymes, proteins that act as the catalysts of biochemical reactions, for the biofuels, specialty industrial processes and health & nutrition markets. Verenium currently has a portfolio of commercialized enzyme products as well as several late-stage product candidates.

For more information on Verenium, please visit

Key Statistics

Ownership: Public

Web Site: Verenium Corporation
Symbol: VRNM



Merck & Co.  Therapeutic antibodies

Company News
Verenium Corporation (VRNM) To Sponsor And Present At The 2013 Biotechnology Industry Organization (BIO) Pacific Rim Summit On Industrial Biotechnology And Bioenergy 12/2/2013 6:50:19 AM
BASF Pays About $51.2 Million for Verenium Corporation (VRNM); Verenium Stock Rises +58.17% at Market Close (September 20, 2013) 9/20/2013 6:30:56 AM
Verenium Corporation (VRNM) to Present at the Rodman & Renshaw Annual Global Investment Conference 9/4/2013 6:37:39 AM
Verenium Corporation (VRNM) Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2013 8/8/2013 6:38:44 AM
Verenium Corporation (VRNM) to Present at Two Upcoming Conferences 8/1/2013 7:01:43 AM
Novus International and Verenium Corporation (VRNM) Introduce the Newest Addition to Novus's Enzyme Solutions Portfolio: CIBENZA® PHYTAVERSE™ 7/26/2013 9:37:24 AM
Verenium Corporation (VRNM) to Announce Second Quarter 2013 Financial Results 7/25/2013 7:21:04 AM
Verenium Corporation (VRNM) to Sponsor and Present at the 2013 Bio World Congress on Industrial Biotechnology 6/11/2013 6:16:26 AM
Verenium Corporation (VRNM) Announces Appointment of Brian Carter as Vice President of Grain Processing 6/10/2013 10:24:32 AM
Verenium Corporation (VRNM) to Present at Two Upcoming Conferences 5/23/2013 6:55:00 AM